Abdurasulova, I.N., Serdyuk, S.E. and Gmiro, V.E., 2007. Comparative study of preventive and therapeutic effects of IEM-1966 and memantine in rats with experimental allergic encephalomyelitis. Bulletin of Experimental Biology and Medicine 144: 217-220 (in Russian).

'Comparative study of preventive and therapeutic effects of IEM-1966 and memantine in rats with experimental allergic encephalomyelitis ' () 144 Bulletin of Experimental Biology and Medicine : 217 -220.

Comparative study of preventive and therapeutic effects of IEM-1966 and memantine in rats with experimental allergic encephalomyelitisBulletin of Experimental Biology and Medicine144217220)| false
• Search Google Scholar

Abdurasulova, I.N. and Klimenko, V.M., 2011a. The role of immune and glial cells in the processes of neurodegeneration. Academic Medicine 11: 12-29 (in Russian).

'The role of immune and glial cells in the processes of neurodegeneration ' () 11 Academic Medicine : 12 -29.

The role of immune and glial cells in the processes of neurodegenerationAcademic Medicine111229)| false
• Search Google Scholar

Abdurasulova, I.N. and Klimenko, V.M., 2011b. Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNS. Neuroscience and Behavior Physiology 41: 364-374.

'Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNS ' () 41 Neuroscience and Behavior Physiology : 364 -374.

Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNSNeuroscience and Behavior Physiology41364374)| false
• Search Google Scholar

Abdurasulova, I.N., Tarasova, E.A., Matsulevich, A.V., Eliseev, A.V., Ermolenko, E.I., Suvorov, A.N. and Klimenko, V.M., 2015. Changes in the qualitative and quantitative composition of gut microbiota in rats during experimental allergic encephalomyelitis. Rossiiskii Fiziologicheskii Zhurnal Imeni im Sechenova 101: 1235-1249 (in Russian).

'Changes in the qualitative and quantitative composition of gut microbiota in rats during experimental allergic encephalomyelitis ' () 101 Rossiiskii Fiziologicheskii Zhurnal Imeni im Sechenova : 1235 -1249.

Changes in the qualitative and quantitative composition of gut microbiota in rats during experimental allergic encephalomyelitisRossiiskii Fiziologicheskii Zhurnal Imeni im Sechenova10112351249)| false
• Search Google Scholar

Aharoni, R., 2014. Immunomodulation neuroprotection and remyelination – the fundamenal therapeutic effects of glatiramer acetate: a critical review. Journal of Autoimmunity 54: 81-92.

'Immunomodulation neuroprotection and remyelination – the fundamenal therapeutic effects of glatiramer acetate: a critical review ' () 54 Journal of Autoimmunity : 81 -92.

Immunomodulation neuroprotection and remyelination – the fundamenal therapeutic effects of glatiramer acetate: a critical reviewJournal of Autoimmunity548192)| false
• Search Google Scholar

Artemiadis, A.K., Anagnostouli, M.C. and Alexopoulos, E.C., 2011. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic rewiew. Neuroepidemiology 36: 109-120.

'Stress as a risk factor for multiple sclerosis onset or relapse: a systematic rewiew ' () 36 Neuroepidemiology : 109 -120.

Stress as a risk factor for multiple sclerosis onset or relapse: a systematic rewiewNeuroepidemiology36109120)| false
• Search Google Scholar

Ascherio, A. and Munger, K.L., 2007. Environmental risk factors for multiple sclerosis, part 1. The role of infection. Annals of Neurology 61: 288-299.

'Environmental risk factors for multiple sclerosis, part 1 ' () 61 Annals of Neurology : 288 -299.

Environmental risk factors for multiple sclerosis, part 1Annals of Neurology61288299)| false
• Search Google Scholar

Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., Ravid, R. and Rajewsky, K., 2000. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. Journal of Experimental Medicine 192: 393-404.

'Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction ' () 192 Journal of Experimental Medicine : 393 -404.

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reactionJournal of Experimental Medicine192393404)| false
• Search Google Scholar

Bel’tiukov, P.P., Abdurasulova, I.N., Tarasova, E.A., Suvorov, A.N., Zakharova, E.T., Sokolov, A.V., Karpenko, M.N. and Ermolenko, E.I., 2009. Influence of probiotic Escherichia coli and enterococci on the immune system of healthy rats. Scientists note Saint-Petersburg State Medical University, Academy I.P. Pavlov 16(2): 54-58 (in Russian).

'Influence of probiotic Escherichia coli and enterococci on the immune system of healthy rats ' () 16 Scientists note Saint-Petersburg State Medical University, Academy I.P. Pavlov : 54 -58.

Influence of probiotic Escherichia coli and enterococci on the immune system of healthy ratsScientists note Saint-Petersburg State Medical University, Academy I.P. Pavlov165458)| false
• Search Google Scholar

Benczur, M., Petranyl, G.G., Palffy, G., Varga, M., Talas, M., Kotsy, B., Földes, I. and Hollan, S.R., 1980. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Clinical and Experimental Immunology 39: 657-662.

'Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor ' () 39 Clinical and Experimental Immunology : 657 -662.

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factorClinical and Experimental Immunology39657662)| false
• Search Google Scholar

Berer, K., Mues, M., Koutrolos, M., Al Rasbi, Z., Boziki, M., Johner, C., Wekerle, H. and Krishnamoorthy, G., 2011. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479: 538-541.

'Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination ' () 479 Nature : 538 -541.

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelinationNature479538541)| false
• Search Google Scholar

Berer, K. and Krishnamoorthy, G., 2012. Commensal gut flora and brain autoimmunity: a love or hate affair? Acta Neuropathology 123: 639-651.

'Commensal gut flora and brain autoimmunity: a love or hate affair? ' () 123 Acta Neuropathology : 639 -651.

Commensal gut flora and brain autoimmunity: a love or hate affair?Acta Neuropathology123639651)| false
• Search Google Scholar

Beriou, G., Costantino, C.M., Ashley, C.W., Yang, L., Kuchroo, V.K., Baecher-Allan, C. and Hafler, D.A., 2009. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113: 4240-4249.

'IL-17-producing human peripheral regulatory T cells retain suppressive function ' () 113 Blood : 4240 -4249.

IL-17-producing human peripheral regulatory T cells retain suppressive functionBlood11342404249)| false
• Search Google Scholar

Bhargava, P. and Mowry, E.M., 2014. Gut microbiom and multiple sclerosis. Current Neurology and Neuroscience Report 14: 492.

'Gut microbiom and multiple sclerosis ' () 14 Current Neurology and Neuroscience Report : 492.

Gut microbiom and multiple sclerosisCurrent Neurology and Neuroscience Report14492)| false
• Search Google Scholar

Bitsch, A., Da Costa, C., Bunkowski, S., Weber, F., Rieckmann, P. and Brück, W., 1998. Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosis. Acta Neuropathology 95: 373-377.

'Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosis ' () 95 Acta Neuropathology : 373 -377.

Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosisActa Neuropathology95373377)| false
• Search Google Scholar

Boster, A., Bartoszek, M.P., O’Connell, C., Pitt, D. and Racke, M., 2011. Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 4: 319-332.

'Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis ' () 4 Therapeutic Advances in Neurological Disorders : 319 -332.

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosisTherapeutic Advances in Neurological Disorders4319332)| false
• Search Google Scholar

Caporro, M., Disanto, G., Gobbi, C. and Zecca, C., 2014. Two decades of subcutaneous Glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment. Patient Prefer Adherence 8: 1123-1134.

'Two decades of subcutaneous Glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment ' () 8 Patient Prefer Adherence : 1123 -1134.

Two decades of subcutaneous Glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatmentPatient Prefer Adherence811231134)| false
• Search Google Scholar

Comabella, M., Balashov, K., Issazadeh, S., Smith, D., Weiner, H.L. and Khoury, S.J., 1998. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. Journal of Clinical Investigation 102: 671-678.

'Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy ' () 102 Journal of Clinical Investigation : 671 -678.

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapyJournal of Clinical Investigation102671678)| false
• Search Google Scholar

Correale, J. and Villa, A., 2008. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. Journal of Neuroimmunology 195: 121-134.

'Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis ' () 195 Journal of Neuroimmunology : 121 -134.

Isolation and characterization of CD8+ regulatory T cells in multiple sclerosisJournal of Neuroimmunology195121134)| false
• Search Google Scholar

Costantino, C.M., Baecher-Allan, C. and Hafler, D.A., 2008. Multiple sclerosis and regulatory T cells. Journal of Clinical Immunology 28: 697-706.

'Multiple sclerosis and regulatory T cells ' () 28 Journal of Clinical Immunology : 697 -706.

Multiple sclerosis and regulatory T cellsJournal of Clinical Immunology28697706)| false
• Search Google Scholar

Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M.G., Biagiotti, R. and Romagnani, S., 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. Journal of Immunology 150: 353-360.

'Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production ' () 150 Journal of Immunology : 353 -360.

Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine productionJournal of Immunology150353360)| false
• Search Google Scholar

Demoulins, T., Gachelin, G., Bequet, D. and Dormont, D., 2003. A biased Vα24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease. Immunology Letters 90: 223-228.

'A biased Vα24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease ' () 90 Immunology Letters : 223 -228.

A biased Vα24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his diseaseImmunology Letters90223228)| false
• Search Google Scholar

Ermolenko, E., Gromova, L., Borshev, Y., Voeikova, A., Karaseva, A., Ermolenko, K., Gruzdkov, A. and Suvorov, A., 2013. Influence of different probiotic lactic acid bacteria on microbiota and metabolism of rats with dysbiosis. Bioscience of Microbiota, Food and Health 32(2): 41-49.

'Influence of different probiotic lactic acid bacteria on microbiota and metabolism of rats with dysbiosis ' () 32 Bioscience of Microbiota, Food and Health : 41 -49.

Influence of different probiotic lactic acid bacteria on microbiota and metabolism of rats with dysbiosisBioscience of Microbiota, Food and Health324149)| false
• Search Google Scholar

Feuerer, M., Hill, J.A., Mathis, D. and Benoist, C., 2009. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Natural Immunology 10: 689-695.

'Foxp3+ regulatory T cells: differentiation, specification, subphenotypes ' () 10 Natural Immunology : 689 -695.

Foxp3+ regulatory T cells: differentiation, specification, subphenotypesNatural Immunology10689695)| false
• Search Google Scholar

Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D. and Anderton, S.M., 2002. B cells regulate autoimmunity by provision of IL-10. Natural Immunology 3: 944-950.

'B cells regulate autoimmunity by provision of IL-10 ' () 3 Natural Immunology : 944 -950.

B cells regulate autoimmunity by provision of IL-10Natural Immunology3944950)| false
• Search Google Scholar

Ganina, K.K., Dugina, Y.L., Zhavbert, E.S., Ertuzun, I.A., Epstein, O.I. and Abdurasulova, I.N., 2015. Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis. Zh Nevrol Psikhiatr im SS Korsakova 115(6): 78-82 (in Russian).

'Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis ' () 115 Zh Nevrol Psikhiatr im SS Korsakova : 78 -82.

Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitisZh Nevrol Psikhiatr im SS Korsakova1157882)| false
• Search Google Scholar

Gimenez, M.A., Sim, J.E. and Russell, J.H., 2004. TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. Journal of Neuroimmunology 151: 116-125.

'TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation ' () 151 Journal of Neuroimmunology : 116 -125.

TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammationJournal of Neuroimmunology151116125)| false
• Search Google Scholar

Gironi, M., Borgiani, B., Mariani, E., Cursano, C., Mendozzi, L., Cavarretta, R., Saresella, M., Clerici, M., Comi, G., Rovaris, M. and Furlan, R., 2014. Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. Journal of Immunology Research 2014: 961863.

'Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment ' () 2014 Journal of Immunology Research : 961863.

Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatmentJournal of Immunology Research2014961863)| false
• Search Google Scholar

Gol-Ara, M., Jadidi-Niaragh, F., Sadria, R., Azizi, G. and Mirshafiey, A., 2012. The role of different subset of regulatory T cells in immunopathogenesis of rheumatoid arthritis. Arthritis 2012: 805875.

'The role of different subset of regulatory T cells in immunopathogenesis of rheumatoid arthritis ' () 2012 Arthritis : 805875.

The role of different subset of regulatory T cells in immunopathogenesis of rheumatoid arthritisArthritis2012805875)| false
• Search Google Scholar

Gold, R., Linington, C. and Lassmann, H., 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.

'Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research ' () 129 Brain : 1953 -1971.

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis researchBrain12919531971)| false
• Search Google Scholar

Gray, E., Thomas, T.L., Betmouni, S., Scolding, N. and Love, S., 2008. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathology 18: 86-95.

'Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis ' () 18 Brain Pathology : 86 -95.

Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosisBrain Pathology188695)| false
• Search Google Scholar

Halpern, R., Agarwal, S., Dembek, C., Borton, L. and Lopez-Bresnahan, M., 2011. Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis. Patient Prefer Adherence 5: 73-84.

'Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis ' () 5 Patient Prefer Adherence : 73 -84.

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysisPatient Prefer Adherence57384)| false
• Search Google Scholar

Hauser, S.L., Waubant, E., Arnold, D.L, Vollmer, T., Antel, J., Fox, R.J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., Langer-Gould, A. and Smith, C.H., 2008. HERMES trial group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. New England Journal of Medicine 358: 676-688.

'HERMES trial group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis ' () 358 New England Journal of Medicine : 676 -688.

HERMES trial group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosisNew England Journal of Medicine358676688)| false
• Search Google Scholar

Johnson, K.P., Brooks, B.R., Cohen, J.A., Ford, C.C., Goldstein, J., Lisak, R.P., Myers, L.W., Panitch, H.S., Rose, J.W. and Schiffer, R.B., 1995. Copolymer 1 reduces relapse rate and improves disability in relapse ingremitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. The Copolimer 1 Multiple Sclerosis Study Group. Neurology 45: 1268-1276.

'Copolymer 1 reduces relapse rate and improves disability in relapse ingremitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. The Copolimer 1 Multiple Sclerosis Study Group ' () 45 Neurology : 1268 -1276.

Copolymer 1 reduces relapse rate and improves disability in relapse ingremitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. The Copolimer 1 Multiple Sclerosis Study GroupNeurology4512681276)| false
• Search Google Scholar

Kakalacheva, K., Münz, C. and Lünemann, J.D., 2011. Viral triggers of multiple sclerosis. Biochimica et Biophysica Acta 1812: 132-140.

'Viral triggers of multiple sclerosis ' () 1812 Biochimica et Biophysica Acta : 132 -140.

Viral triggers of multiple sclerosisBiochimica et Biophysica Acta1812132140)| false
• Search Google Scholar

Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B. and Prat, A., 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Medicine 13: 1173-1175.

'Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation ' () 13 Nature Medicine : 1173 -1175.

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammationNature Medicine1311731175)| false
• Search Google Scholar

Kobayashi, T., Kato, I., Nanno, M., Shida, K., Shibuya, K., Matsuoka, Y. and Onoue, M., 2010. Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacolofy and Immunotoxicology 32: 116-124.

'Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis ' () 32 Immunopharmacolofy and Immunotoxicology : 116 -124.

Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitisImmunopharmacolofy and Immunotoxicology32116124)| false
• Search Google Scholar

Kuenz, B., Lutterotti, A., Ehling, R., Gneiss, C., Haemmerle, M., Rainer, C., Deisenhammer, F., Schocke, M., Berger, T. and Reindl, M., 2008. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 3: e2559.

'Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis ' () 3 PLoS One : e2559.

Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisPLoS One3e2559)| false
• Search Google Scholar

Kwon, H.K., Kim, G.C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.E., Nam, J.H. and Im, S.H., 2013. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clinical Immunology 146: 217-227.

'Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response ' () 146 Clinical Immunology : 217 -227.

Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune responseClinical Immunology146217227)| false
• Search Google Scholar

Lassmann, H., Van Horssen, J. and Mahad, D., 2012. Progressive multiple sclerosis: pathology and pathogenesis. Nature Reviews Neurology 8: 647-656.

'Progressive multiple sclerosis: pathology and pathogenesis ' () 8 Nature Reviews Neurology : 647 -656.

Progressive multiple sclerosis: pathology and pathogenesisNature Reviews Neurology8647656)| false
• Search Google Scholar

Lalive, P.H., Neuhaus, O., Benkhoucha, M., Burger, D., Hohfeld, R., Zamvil, S.S. and Weber, M.S., 2011. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanisms of action. CNS Drugs 25: 401-414.

'Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanisms of action ' () 25 CNS Drugs : 401 -414.

Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanisms of actionCNS Drugs25401414)| false
• Search Google Scholar

Lauer, K., 2014. Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits. International Journal of Molecular Science 15: 3533-3545.

'Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits ' () 15 International Journal of Molecular Science : 3533 -3545.

Notes on the epidemiology of multiple sclerosis, with special reference to dietary habitsInternational Journal of Molecular Science1535333545)| false
• Search Google Scholar

Lavasani, S., Dzhambazov, B., Nouri, M., Fak, F., Buske, S., Molin, G., Thoriacius, H., Alenfall, J., Jepperson, B. and Weström, B., 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. Plos One 5: e9009.

'A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells ' () 5 Plos One : e9009.

A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cellsPlos One5e9009)| false
• Search Google Scholar

Lee, Y.K., Menezes, J.S., Umesaki, Y. and Mazmanian, S.K., 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the USA 108 (Suppl. 1): 4615-4622.

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis 4615 4622

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis46154622)| false
• Search Google Scholar

Levinthal, D.J., Rahman, A., Nusrat, S., O’Leary, M., Heyman, R. and Bielefeldt, K., 2013. Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis. Multiple Sclerosis International 2013: 319201.

'Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis ' () 2013 Multiple Sclerosis International : 319201.

Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosisMultiple Sclerosis International2013319201)| false
• Search Google Scholar

Libbey, J.E. and Fujinami, R.S., 2010. Potential triggers of MS. Results and Problems in Cell Differentiation 51: 24-42.

'Potential triggers of MS ' () 51 Results and Problems in Cell Differentiation : 24 -42.

Potential triggers of MSResults and Problems in Cell Differentiation512442)| false
• Search Google Scholar

Lock, C., Oksenberg, J. and Steinman, L., 1999. The role of TNFα and lymphotoxin in demyelinating disease. Annals of the Rheumatic Diseases 58 (Suppl. I): I121-I128.

'The role of TNFα and lymphotoxin in demyelinating disease ' () 58 Annals of the Rheumatic Diseases : I121 -I128.

The role of TNFα and lymphotoxin in demyelinating diseaseAnnals of the Rheumatic Diseases58I121I128)| false
• Search Google Scholar

Mars, L.T., Laloux, V., Goude, K., Desbois, S., Saoudi, A., Van Kaer, L., Lassmann, H., Herbelin, A., Lehuen, A. and Liblau, R.S., 2002. Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. Journal of Immunology 168: 6007-6011.

'Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice ' () 168 Journal of Immunology : 6007 -6011.

Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic miceJournal of Immunology16860076011)| false
• Search Google Scholar

Matute, C., Alberdi, E., Domercq, M., Sanchez-Gomez, M.V., Perez-Samartin, A. and Rodriguez-Antiguedad, A., 2007. Excitotoxic damage to white matter. Journal of Anatomy 210: 693-702.

'Excitotoxic damage to white matter ' () 210 Journal of Anatomy : 693 -702.

Excitotoxic damage to white matterJournal of Anatomy210693702)| false
• Search Google Scholar

Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G., 2000. Multiple sclerosis. New England Journal of Medicine 343: 938-952.

'Multiple sclerosis ' () 343 New England Journal of Medicine : 938 -952.

Multiple sclerosisNew England Journal of Medicine343938952)| false
• Search Google Scholar

Ochoa-Reparaz, J. and Kasper, L.H., 2014. Gut microbiome as the risk factors in central nervous system autoimmunity. FEBS Letters 588: 4214-4222.

'Gut microbiome as the risk factors in central nervous system autoimmunity ' () 588 FEBS Letters : 4214 -4222.

Gut microbiome as the risk factors in central nervous system autoimmunityFEBS Letters58842144222)| false
• Search Google Scholar

Ochoa-Reparaz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Foureau, D.M., Haque-Begum, S. and Kasper, L.H., 2009. Role of gut commensal microbiota in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 183: 6041-6050.

'Role of gut commensal microbiota in the development of experimental autoimmune encephalomyelitis ' () 183 Journal of Immunology : 6041 -6050.

Role of gut commensal microbiota in the development of experimental autoimmune encephalomyelitisJournal of Immunology18360416050)| false
• Search Google Scholar

O’Gorman, C., Lucas, R. and Taylor, B., 2012. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. International Journal of Molecular Science 13: 11718-11752.

'Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms ' () 13 International Journal of Molecular Science : 11718 -11752.

Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsInternational Journal of Molecular Science131171811752)| false
• Search Google Scholar

Poser, C.M., 2006. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect. Clinical Neurology and Neurosurgery 108: 227-233.

'The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect ' () 108 Clinical Neurology and Neurosurgery : 227 -233.

The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effectClinical Neurology and Neurosurgery108227233)| false
• Search Google Scholar

Preziosi, G., Raptis, D.A., Raeburn, A., Thiruppathy, K., Panicker, J. and Emmanuel, A., 2013. Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease. European Journal of Gastroenterology and Hepatology 25: 1044-1050.

'Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease ' () 25 European Journal of Gastroenterology and Hepatology : 1044 -1050.

Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the diseaseEuropean Journal of Gastroenterology and Hepatology2510441050)| false
• Search Google Scholar

Ries, S., Hilgenberg, E., Lampropoulou, V., Shen, P., Dang, V.D., Wilantri, S., Sakwa, I. and Fillatreau, S., 2014. B-type suppression: a role played by ‘regulatory B cells’ or ‘regulatory plasma cells’? European Journal of Immunology 44: 1251-1257.

'B-type suppression: a role played by ‘regulatory B cells’ or ‘regulatory plasma cells’? ' () 44 European Journal of Immunology : 1251 -1257.

B-type suppression: a role played by ‘regulatory B cells’ or ‘regulatory plasma cells’?European Journal of Immunology4412511257)| false
• Search Google Scholar

Robinson, A.P., Harp, C.T., Noronha, A. and Miller, S.D., 2014. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handbook of Clinical Neurology 122: 173-189.

'The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment ' () 122 Handbook of Clinical Neurology : 173 -189.

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatmentHandbook of Clinical Neurology122173189)| false
• Search Google Scholar

Rumah, K.R., Linden, J., Fischetti, V.A. and Vartanian, T., 2013. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS One 8: e76359.

'Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease ' () 8 PLoS One : e76359.

Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the diseasePLoS One8e76359)| false
• Search Google Scholar

Sawcer, S., Franklin, R. and Ban, M., 2014, Multiple sclerosis genetic. Lancet Neurology 13(7): 700-709.

'Multiple sclerosis genetic ' () 13 Lancet Neurology : 700 -709.

Multiple sclerosis geneticLancet Neurology13700709)| false
• Search Google Scholar

Simmons, S.B., Pierson, E.R., Lee, S.Y. and Goverman, J.M., 2013. Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunology 34: 410-422.

'Modeling the heterogeneity of multiple sclerosis in animals ' () 34 Trends Immunology : 410 -422.

Modeling the heterogeneity of multiple sclerosis in animalsTrends Immunology34410422)| false
• Search Google Scholar

Smith, T., Hewson, A.K., Kingsley, C.I., Leonard, J.P. and Cuzner, M.L., 1997. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. American Journal of Pathology 150: 1909-1917.

'Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat ' () 150 American Journal of Pathology : 1909 -1917.

Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis ratAmerican Journal of Pathology15019091917)| false
• Search Google Scholar

Sospedra, M. and Martin, R., 2005. Immunology of multiple sclerosis. Annual Review of Immunology 23: 683-747.

'Immunology of multiple sclerosis ' () 23 Annual Review of Immunology : 683 -747.

Immunology of multiple sclerosisAnnual Review of Immunology23683747)| false
• Search Google Scholar

Steiner, I., Nisipianu, P. and Wirguin, I., 2001. Infection and the etiology and pathogenesis of multiple sclerosis. Current Neurological and Neuroscience Report 1: 271-276.

'Infection and the etiology and pathogenesis of multiple sclerosis ' () 1 Current Neurological and Neuroscience Report : 271 -276.

Infection and the etiology and pathogenesis of multiple sclerosisCurrent Neurological and Neuroscience Report1271276)| false
• Search Google Scholar

Suvorov, A.N., Zaharenko, S.M. and Alekhina, G.G., 2003. Энтерококки как пробиотики выбора. Clinical Nutrition 1: 26-29 (in Russian).

'Энтерококки как пробиотики выбора ' () 1 Clinical Nutrition : 26 -29.

Энтерококки как пробиотики выбораClinical Nutrition12629)| false
• Search Google Scholar

Takata, K., Kinoshita, M., Okuno, T., Moriya, M., Kohda, T., Honorat, J.A., Sugimoto, T., Kumanogoh, A., Kayama, H., Takeda, K., Sakoda, S. and Nakatsuji, Y., 2011. The lactic acid bacterium Pediococcus acidilactici supresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells. PLoS One 6: e27644.

'The lactic acid bacterium Pediococcus acidilactici supresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells ' () 6 PLoS One : e27644.

The lactic acid bacterium Pediococcus acidilactici supresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cellsPLoS One6e27644)| false
• Search Google Scholar

Tarasova, E., Yermolenko, E., Donets, V., Sundukova, Z., Bochkareva, A., Borschev, I., Suvorova, M., Ilyasov, I., Simanenkov, V. and Suvorov, A., 2010. The influence of probiotic enetrococci on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics. Beneficial Microbes 1: 265-270.

'The influence of probiotic enetrococci on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics ' () 1 Beneficial Microbes : 265 -270.

The influence of probiotic enetrococci on the microbiota and cytokines expression in rats with dysbiosis induced by antibioticsBeneficial Microbes1265270)| false
• Search Google Scholar

Vartanian, T., Li, Y., Zhao, M. and Stefansson, K., 1995. Interferon-gamma-induced oligodendrocyte cell death: implication for the pathogenesis of multiple sclerosis. Molecular Medicine 1: 732-743.

'Interferon-gamma-induced oligodendrocyte cell death: implication for the pathogenesis of multiple sclerosis ' () 1 Molecular Medicine : 732 -743.

Interferon-gamma-induced oligodendrocyte cell death: implication for the pathogenesis of multiple sclerosisMolecular Medicine1732743)| false
• Search Google Scholar

Westall, F.C., 2006. Molecular mimicry revisited: gut bacteria and multiple sclerosis. Journal of Clinical Microbiology 44: 2099-2104.

'Molecular mimicry revisited: gut bacteria and multiple sclerosis ' () 44 Journal of Clinical Microbiology : 2099 -2104.

Molecular mimicry revisited: gut bacteria and multiple sclerosisJournal of Clinical Microbiology4420992104)| false
• Search Google Scholar

Ziemssen, T., Neuhaus, O. and Hohlfeld, R., 2001. Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Safety 24: 979-990.

'Risk-benefit assessment of glatiramer acetate in multiple sclerosis ' () 24 Drug Safety : 979 -990.

Risk-benefit assessment of glatiramer acetate in multiple sclerosisDrug Safety24979990)| false
• Search Google Scholar